Sponsor Pipeline

Novelwise Pharmaceutical Corporation Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
3
Recruiting
1
Disease Areas
Active Trials by Phase
Phase 1/2
3
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT07136181 Evaluation of the Safety, Efficacy, and Pharmacokinetics of NBM-BMX in Patients With… Metastatic Uveal Melanoma Recruiting
NCT06012695 NBM-BMX Administered Orally to Patients With Solid Tumors or Newly Diagnosed Glioblastoma Malignant Neoplasm Recruiting
NCT07569042 A Rollover Study of NBM-BMX in Combination With Temozolomide in Patients With Newly… Malignant Neoplasm of Brain Recruiting
Disease Areas
Melanoma (1)
Get alerts when Novelwise Pharmaceutical Corporation's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free